Evidence map›Paper›PMID 38481921›Full record

ArticleCureus2024

Post-renal Biopsy Retroperitoneal Haematoma Accompanied by Decreased Coagulation Factor XIII Levels in Immunoglobulin A Nephropathy.

Yoko Hirano, Shoichiro Kanda, Moe Hidaka, Motohiro Kato, Masako Nishikawa, Yutaka Yatomi, Hiroyuki Tanaka, Akiko Kinumaki, Yuko Kajiho, Yutaka Harita

Open access · diamondAbstract readCase Reports
In one paragraph

Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 94% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Yoko HiranoDepartment of Pediatrics, The University of Tokyo, Tokyo, JPN.
Shoichiro KandaDepartment of Pediatrics, The University of Tokyo, Tokyo, JPN.
Moe HidakaDepartment of Pediatrics, The University of Tokyo, Tokyo, JPN.
Motohiro KatoDepartment of Pediatrics, The University of Tokyo, Tokyo, JPN.
Masako NishikawaDepartment of Clinical Laboratory Medicine, The University of Tokyo, Tokyo, JPN.
Yutaka YatomiDepartment of Clinical Laboratory Medicine, The University of Tokyo, Tokyo, JPN.
Hiroyuki TanakaDepartment of Pediatrics, The University of Tokyo, Tokyo, JPN.
Akiko KinumakiDepartment of Pediatrics, The University of Tokyo, Tokyo, JPN.
Yuko KajihoDepartment of Pediatrics, The University of Tokyo, Tokyo, JPN.
Yutaka HaritaDepartment of Pediatrics, The University of Tokyo, Tokyo, JPN.
University of Tokyo Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Post-biopsy bleeding is the primary complication of renal biopsy. Retroperitoneal haematoma is a rare but severe bleeding complication; it commonly occurs among patients who have risk factors or vascular lesions. The bleeding risks in patients with immunoglobulin A (IgA) nephropathy (IgAN) have been discussed in the literature, but clinical data are lacking. Here, we report a case of a post-biopsy retroperitoneal haematoma accompanied by decreased coagulation factor XIII (FXIII) in a patient with IgAN. A 14-year-old male patient with haematuria and proteinuria but no bleeding or family history of bleeding underwent pre-renal biopsy evaluation that showed no coagulation abnormalities. He underwent percutaneous renal biopsy, and the histopathological diagnosis was IgAN. Five days after the biopsy, he presented with delayed bleeding from a retroperitoneal haematoma. During the workup for undiagnosed haemorrhagic diatheses, a mildly decreased FXIII level was discovered. This result suggested the possibility of bleeding complications associated with decreased FXIII. Some bleeding diatheses, including FXIII deficiency, cannot be evaluated in routine pre-biopsy coagulation tests. Mild FXIII deficiency can increase the risk of post-biopsy bleeding complications. Therefore, physicians should consider unevaluated haemorrhagic diatheses when a patient presents with major bleeding complications or delayed bleeding following renal biopsy without any known risk factors or vascular lesions.

Indexed as

biopsy complicationsfactor xiiihaematomaiga nephropathypre-renal biopsy evaluation

Identifiers

PMID38481921
PMCPMC10932726
OpenAlexW4392784461

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.